ahlam1399
10-01-2016, 01:00 PM
J&J psoriasis drug tops placebo, Humira in late stage study
(Reuters) - An experimental biotech drug developed by Johnson & Johnson proved more effective at clearing moderate to severe cases of the skin condition plaque psoriasis than a placebo or Abbvie Inc's big-selling Humira, according to data from a late stage study presented on Saturday.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=TyAb3UXnexU:CQ5kcw3t1oI:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=TyAb3UXnexU:CQ5kcw3t1oI:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=TyAb3UXnexU:CQ5kcw3t1oI:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=TyAb3UXnexU:CQ5kcw3t1oI:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=TyAb3UXnexU:CQ5kcw3t1oI:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/TyAb3UXnexU
(Reuters) - An experimental biotech drug developed by Johnson & Johnson proved more effective at clearing moderate to severe cases of the skin condition plaque psoriasis than a placebo or Abbvie Inc's big-selling Humira, according to data from a late stage study presented on Saturday.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=TyAb3UXnexU:CQ5kcw3t1oI:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=TyAb3UXnexU:CQ5kcw3t1oI:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=TyAb3UXnexU:CQ5kcw3t1oI:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=TyAb3UXnexU:CQ5kcw3t1oI:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=TyAb3UXnexU:CQ5kcw3t1oI:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/TyAb3UXnexU